Results 81 to 90 of about 22,112 (212)
What's new? Mitogen‐activated protein kinase (MAPK) inhibitors are promising treatments for pediatric Langerhans cell histiocytosis (LCH), a rare heterogeneous neoplasm that often affects multiple organ systems. Which MAPK inhibitors are most effective against LCH remains uncertain.
Xue Tang +5 more
wiley +1 more source
Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in a ten-year-old girl accompanied by posterior reversible encephalopathy syndrome and disseminated herpes simplex virus infection [PDF]
可逆性後頭葉白質脳症は通常臨床的には頭痛・痙攣・視覚障害等の神経症状で発症するしばしば認める疾患である.一方,播種性ヘルペス感染症は免疫不全患者で認める感染症である.今回我々は,EBウイルス関連血球貪食症候群に対するエトポシド・プレドニゾロン・シクロスポリンを用いた多剤併用化学療法中に,シクロスポリン関連可逆性後頭葉白質脳症と播種性ヘルペス感染症と診断された10歳女児を経験したので報告する.EBウイルス関連血球貪食症候群に対する併用療法は当初有効であったが ...
板倉 隆太 +5 more
core
ABSTRACT Mosunetuzumab is approved as an intravenous (IV) formulation for relapsed/refractory (R/R) follicular lymphoma (FL) after ≥ 2 prior therapies. A subcutaneous (SC) formulation, aiming to improve patient safety and convenience, has been developed.
Nancy L. Bartlett +20 more
wiley +1 more source
Défaut d’exocytose des granules lytiques : Plusieurs causes, un même effet [PDF]
Une réponse immune exagérée, incontrôlée et le plus souvent fatale, connue sous le nom de syndrome hémophagocytaire (SH), est associée à un défaut de la fonction cytotoxique des lymphocytes T et natural killer (NK).
de Saint Basile, Geneviève +4 more
core
An Unusual Case of Classic Hodgkin Lymphoma With Strong Expression of B‐Cell Markers
International Journal of Laboratory Hematology, EarlyView.
Christopher Liwski +3 more
wiley +1 more source
ABSTRACT Ovarian Cancer (OC), the deadliest gynecological malignancy, poses a major therapeutic challenge in advanced stages owing to its high recurrence rate and metastatic potential. In this regard, it is noteworthy that immunotherapy has recently gained significant attention in OC treatment, a phenomenon attributable to notable advances in over‐the ...
Liying Wang +4 more
wiley +1 more source
Macrophage Activation Syndrome [PDF]
Macrophage activation syndrome (MAS) is a potentially life-threatening complication of rheumatic diseases such as systemic juvenile idiopathic arthritis (sJIA) and systemic lupus erythematosus.
Clarke, Sarah L N +2 more
core +2 more sources
Graphical abstract illustrating the phenotype‐guided therapeutic approach in severe adult HLH/MAS with SPTCL‐like panniculitis, demonstrating clinical and biochemical response following sequential treatment with therapeutic plasma exchange, intravenous immunoglobulin, and cyclosporine.
Hatem Mousa Taha +2 more
wiley +1 more source
Secondary hemophagocytic lymphohistiocytosis in children with brucellosis: report of three cases
Brucellosis is a systemic zoonotic infectious disease that may cause fever, fatigue, sweating, arthritis, hepatosplenomegaly, cytopenia, and lymphadenopathy. It continues to be an important health problem worldwide.
Yöntem Yaman +6 more
doaj +1 more source
ABSTRACT Phagocytic activity of mesothelial cells is a rare phenomenon requiring careful differentiation from histiocytic hemophagocytosis to ensure appropriate patient management, as these phenomena could exhibit distinct clinical implications. In this study, we report a case of phagocytic mesothelial cells found in pericardial effusion that developed
Hidetoshi Satomi +5 more
wiley +1 more source

